Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Clinical trial NCT05642078 · COMPLETED

Trial details

NCT number: NCT05642078
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prevention of Influenza

Start date: 2023-02-18
Primary completion: 2024-01-05
Enrollment: 2550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.